Weight loss
One goal, one intake, one program that adapts.
Step 1 of 10
Pick one to begin. Most people finish in about 3 minutes.
See if you qualify


Pricing
Including what you are charged today. No codes, no first-month tricks, no price increase when your dose changes.

Once-weekly appetite support, steady and consistent. Same price at every dose. Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not the same as Wegovy, Ozempic, Zepbound or Mounjaro. They are not generic versions of any brand-name drug.
How it works
01
A few questions about your health and your goal. About 3 minutes.
02
An independent licensed healthcare provider will determine if treatment is appropriate.
03
Sourced from licensed U.S. pharmacies. Discreet packaging, tracked delivery.
Compounded drugs are not FDA-approved. Prescription required; not everyone qualifies.
Compounded semaglutide and compounded tirzepatide
Warning: possible risk of thyroid C-cell tumors
In studies in rodents, semaglutide and tirzepatide caused thyroid C-cell tumors. It is not known whether they cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in people. Do not use if you or any of your family have ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician right away if you get a lump or swelling in your neck, trouble swallowing, hoarseness, or shortness of breath.
Semaglutide is a GLP-1 receptor agonist and tirzepatide is a dual GIP/GLP-1 receptor agonist. Both are prescription injections used, where a licensed clinician decides it is appropriate, alongside a reduced-calorie diet and increased physical activity for weight management.
Compounded semaglutide and tirzepatide are prepared by state-licensed compounding pharmacies. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Treatment requires an online evaluation with an independent licensed healthcare provider, who decides whether it is appropriate for you; not everyone is approved.
Before starting, tell your clinician if you have or have had pancreatitis (inflammation of the pancreas), kidney, liver or pancreas problems, thyroid tumors, gallbladder problems, diabetic retinopathy, severe stomach or digestion problems, depression or thoughts of suicide, or if you are pregnant, breastfeeding, or planning to become pregnant (these medications should be stopped before a planned pregnancy; your clinician will advise when), or if you are taking insulin, a sulfonylurea, or any other medications. Tirzepatide may make birth control pills less effective; use a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase.
Nausea, vomiting, diarrhea, constipation, indigestion, mild stomach (abdominal) pain, and fatigue. These are usually mild but tell your clinician if they persist or worsen.